Skip to content
The GLP-1 Verdict
Menu
Ranked #100 · Grade C

Kina review

Kina is a menopause-care telehealth platform where GLP-1 is the weight-loss treatment, offered alongside HRT, peptide, and compounded options for menopause symptoms.

Visit Kina Assume we may earn a commission, at no cost to you. It never changes The Verdict Score, nor a word of this review.
Semaglutide
From $179/mo (starting dose, plus a separate fee, compounded)
Tirzepatide
From $179/mo (starting dose, compounded)
Coverage
Not disclosed
Brand-name
Compounded only

The scorecard

Kina scored on our six published factors. See the methodology.

Real-world results80/100
Price honesty50/100
Prescriber access60/100
Formulary choice82/100
Cancellation fairness92/100
Member support84/100

What we like

  • Menopause-specialized care — GLP-1 weight treatment alongside HRT, peptide, and compounded options for menopause symptoms
  • Prescribed and monitored by named board-certified physicians at Arora Health & Aesthetics, with dose adjustments included
  • Verifiable LegitScript certification (seal ID 50917967)
  • GLP-1 from $179/month with $0 membership fees, FSA/HSA eligibility, free shipping, and cancel-anytime
  • Compounded semaglutide and tirzepatide, 100% online with a roughly 2-minute intake

The caveats

  • Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • Built for women navigating menopause — less tailored if that is not your situation
  • A separate $50 physician consultation fee applies on top of the medication price
  • The compounding pharmacy partner is not named, and the full list of served states is not published

The verdict

Best for: Women in menopause wanting GLP-1 weight care alongside HRT, from board-certified physicians. Kina is a menopause-care telehealth platform where GLP-1 is the weight-loss treatment, offered alongside HRT, peptide, and compounded options for menopause symptoms.

Ranked #100 of 499 providers we have reviewed — for comparison, read our ruling on CoreAge Rx, our #1 pick. On the board it sits between Ivy Rx, 73/100 above and Layla at 73/100 below, with the Liberty ruling the next one down.

If that ruling leaves you undecided, the 7 programmes we rank against Kina are graded on the same six factors and listed in score order. We have also ruled on it directly: CoreAge Rx vs Kina goes to CoreAge Rx, 94/100 to 73/100.

Visit Kina

Compare with other providers

All 498 other providers we've reviewed, in our overall ranking order.

Every other program we track (492)

Pricing, states and verification reflect Kina's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Kina's site. Not medical advice; see our disclosure.

← Back to all rankings